Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jan 2026

IRES Mutation Confers a Replicative Advantage to SVA by Enhancing Translation Efficiency

The internal ribosome entry site (IRES) is a cis‐acting element found in certain RNA viruses. In virus‐infected cells, the Senecavirus A (SVA) IRES can directly recruit the small ribosomal subunit to an internal initiation codon on the mRNA, enabling translation initiation independently of both the 5′ cap structure of the viral genome and the host cell eukaryotic initiation factor 4F (eIF4F). As a small RNA virus, SVA frequently accumulates genetic mutations during transmission. This study aimed to characterize the mutational and evolutionary patterns of the SVA genome during its transmission within host cells exhibiting enhanced innate immunity. SVA was serially passaged for 80 generations in preactivated 3D4/21 cells that had been established in an antiviral innate immune state. During serial passaging, two stable single‐nucleotide mutations were consistently identified in the IRES region of the viral genomic RNA from passages 60–80: a uridine (U) insertion at genomic position 109, and a guanine (G)‐to‐adenine (A) substitution at position 265. Furthermore, the rescued SVA mutants harboring these mutations exhibited significantly higher replication titers than the parental strain. Notably, our results indicated that the mutant virus was unable to evade host antiviral innate immunity, whereas it significantly enhanced the translational activity of the SVA IRES. Collectively, these findings provide a foundation for understanding how single nucleotide polymorphisms (SNPs) in the 5′ untranslated region (UTR) region influence viral IRES activity and the replication capacity of recombinant viruses.

Tao Li, Wen Dang, Weiwei Li et al. · 0 citations
Open access Jul 2026

MGF100 but not MGF300 family is a potential multigene-deleted target for ASFV attenuation and live attenuated vaccine development

ABSTRACT African swine fever (ASF) is a highly contagious and lethal disease, but few therapeutic options are available for its treatment. Therefore, there is an urgent need for the development of safe and effective vaccines. In this regard, we described the differential effect of deletion of whole MGF100 and MGF300 families from genotype II highly virulent strains on African swine fever virus (ASFV) replication, virulence, and induction of protection. The resulting ASFV-Δ100 and ASFV-Δ300 mutants demonstrated reduced growth kinetics in vitro, with the former displaying aberrant virus morphogenesis. ASFV-Δ100 was efficiently attenuated, whereas ASFV-Δ300 retained its virulence. In the homologous lethal challenge, the two mutants achieved the same protection rate, with the former providing more protection against pathology in organs. Mechanistically, we found that ASFV-Δ100 was capable of inducing a robust innate immune response in vitro and a consistent P30 antibody response in vivo. In conclusion, the MGF100 family is a potential multigene-deleted target for ASFV live-attenuated vaccine development.

Wen Dang, Fan Xu, Yu Du et al. · 0 citations